Enfusion (ENFN)
(Delayed Data from NYSE)
$8.04 USD
+0.15 (1.90%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $8.03 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ENFN 8.04 +0.15(1.90%)
Will ENFN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ENFN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENFN
Enfusion (ENFN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Enfusion, Inc. (ENFN) Q2 Earnings and Revenues Miss Estimates
ENFN: What are Zacks experts saying now?
Zacks Private Portfolio Services
STNE or ENFN: Which Is the Better Value Stock Right Now?
Implied Volatility Surging for Enfusion (ENFN) Stock Options
Enfusion (ENFN) Reports Q1 Earnings: What Key Metrics Have to Say
Other News for ENFN
Morgan Stanley Keeps Their Buy Rating on Enfusion (ENFN)
Enfusion Inc (ENFN) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
Enfusion reports Q2 EPS 5c, consensus 6c
Enfusion Announces Second Quarter 2024 Results